Declining detection rates for APC and biallelic MUTYH variants in polyposis patients, implications for DNA testing policy-Reference-Cited by-同舟云学术

Declining detection rates for APC and biallelic MUTYH variants in polyposis patients, implications for DNA testing policy

Published:2019-09-16 Issue:2 Volume:28 Page:222-230
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Terlouw Diantha,Suerink Manon,Singh Sunny S.,Gille Hans J. J. P.,Hes Frederik J.^ORCID,Langers Alexandra M. J.,Morreau Hans,Vasen Hans F. A.,Vos Yvonne J.,van Wezel Tom^ORCID,Tops Carli. M.,ten Broeke Sanne W.,Nielsen Maartje^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics

Link

http://www.nature.com/articles/s41431-019-0509-z.pdf

Reference32 articles.

1. Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359:592–7.

2. Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet. 2003;361:1491–5.

3. Hes FJ, Ruano D, Nieuwenhuis M, Tops CM, Schrumpf M, Nielsen M, et al. Colorectal cancer risk variants on 11q23 and 15q13 are associated with unexplained adenomatous polyposis. J Med Genet. 2014;51:55–60.

4. van Hees F, Saini SD, Lansdorp-Vogelaar I, Vijan S, Meester RG, de Koning HJ, et al. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness. Gastroenterology. 2015;149:1425–37.

5. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253:661–5.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Genetic Testing Strategy for Suspected Attenuated Adenomatous Polyposis: Effective Solutions in Public Health Systems;2024-07-01

2. Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision;British Journal of Surgery;2024-05

3. Solving Missing Heritability in Patients With Familial Adenomatous Polyposis With DNA-RNA Paired Testing;JCO Precision Oncology;2024-05

4. Use of multi-gene panels in patients at high risk of hereditary digestive cancer: Position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium;Gastroenterología y Hepatología (English Edition);2024-03

5. Multiple colorectal adenomas syndrome: The role of MUTYH mutation and the polyps’ number in clinical management and colorectal cancer risk;Digestive and Liver Disease;2023-12